Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | Director | September 25, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 713,258 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Sale · Disposed 39,051 · Balance 713,258 F1: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. F2: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
F2: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 29, 2026 00:26 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 39,051 | $3.29 | $128,477.79 |
DisclosureSEC source: 0001193125-26-405736 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 713,258 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. F2 · price: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · acquired: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. Read SEC document |
| September 10, 2026 Filed Sep 15, 2026 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 33,558 | $3.81 | $127,855.98 |
DisclosureSEC source: 0001193125-26-391003 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752,309 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. F2 · price: The weighted average sales price of the reported transaction was $3.81 based on a range of prices between $3.76 and $3.87. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · acquired: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 00:44 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 39,051 | $4.06 | $158,547.06 |
DisclosureSEC source: 0001193125-26-343016 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 785,867 F2 · price: The weighted average sales price of the reported transaction was $4.06 based on a range of prices between $3.86 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · acquired: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. Read SEC document |
| July 17, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 52,485 | $4.06 | $213,089.10 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · nonDerivative · entry 5 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 824,918 F4 · price: The weighted average sales price of the reported transaction was $4.06 based on a range of prices between $3.98 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3 · acquired: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionPerformance Restricted Stock Unit · Derivative | 93,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · derivative · entry 6 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 93,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F1 · kind: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. F1 · derivative.exercise_date: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. F1 · derivative.expiration_date: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. F1 · balance_after: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 4,634 | $4.09 | $18,953.06 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · nonDerivative · entry 4 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 877,403 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 4,073 | $4.09 | $16,658.57 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · nonDerivative · entry 3 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 882,037 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 15,688 | $4.09 | $64,163.92 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 886,110 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 01:42 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionCommon Stock, $0.01 Par Value | 93,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-308129 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 901,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. F1 · balance_after: A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:56 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit · Derivative | 82,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237438 · ownership.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,781 Underlying: Common Stock, $0.01 Par Value · 82,781 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 12, 2026 Filed May 14, 2026 00:30 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 16,940 | $3.29 | $55,732.60 |
DisclosureSEC source: 0001193125-26-222311 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 808,008 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. F3 · price: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.25 and $3.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 5,560 | $3.52 | $19,571.20 |
DisclosureSEC source: 0001193125-26-222311 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 824,948 F1 · shares: Represents shares withheld to pay tax withholding obligations due on the date of vesting of the Restricted Stock Units originally granted on May 10, 2022. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:50 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 45,025 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001193125-26-086378 · ownership.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,025 Underlying: Stock Options · 45,025 shares Expires 2027-08-23 F1 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 26, 2026, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 00:51 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 75,367 | $3.94 | $296,945.98 |
DisclosureSEC source: 0000950170-25-096744 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 830,508 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 16, 2024. F3 · price: The weighted average sales price of the reported transaction was $3.94 based on a range of prices between $3.91 and $3.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:51 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 19,383 | $3.85 | $74,624.55 |
DisclosureSEC source: 0000950170-25-096744 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 905,875 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 00:07 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 64,085 | $4.00 | $256,340.00 |
DisclosureSEC source: 0000950170-25-084587 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 925,258 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F2 · price: The weighted average sales price of the reported transaction was $4.00 based on a range of prices between $3.91 and $4.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 20, 2025 Filed May 21, 2025 01:45 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 12,078 | $4.40 | $53,143.20 |
DisclosureSEC source: 0000950170-25-075536 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 989,343 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F3 · price: The weighted average sales price of the reported transaction was $4.40 based on a range of prices between $4.37 and $4.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 19, 2025 Filed May 21, 2025 01:45 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 5,190 | $4.37 | $22,680.30 |
DisclosureSEC source: 0000950170-25-075536 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,001,421 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 14, 2025 Filed May 16, 2025 01:35 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · derivative · entry 5 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F6 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F6 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F6 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 13, 2025 Filed May 16, 2025 01:35 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 80,144 | $4.69 | $375,875.36 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · nonDerivative · entry 4 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,006,611 F3 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 16, 2024. F4 · price: The weighted average sales price of the reported transaction was $4.69 based on a range of prices between $4.65 and $4.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 12, 2025 Filed May 16, 2025 01:35 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 6,441 | $4.56 | $29,370.96 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · nonDerivative · entry 3 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,086,755 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 12, 2025 Filed May 16, 2025 01:35 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 87,430 | $4.56 | $398,680.80 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,093,196 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 10, 2025 Filed May 16, 2025 01:35 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 105,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,180,626 F1 · kind: A previously reported restricted stock unit award granted on May 10, 2022 vested on May 10, 2025 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on May 9, 2025 was not less than the closing price on May 10, 2022 and (ii) MannKind's total shareholder return (TSR) over the period from May 10, 2022 to May 10, 2025 was at the 73.9th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 196% of target, resulting in a total share delivery of 215,600 shares. The acquisition of 110,000 shares pursuant to the restricted stock award was reported in Table I of the Form 4 filed by the Reporting Person on May 12, 2022. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,512 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-130728 · ownership.xml · derivative · entry 5 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 22,512 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,512 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-130728 · ownership.xml · derivative · entry 4 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 22,512 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,512 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-130728 · ownership.xml · derivative · entry 3 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 22,512 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 67,536 | $6.89 | $465,323.04 |
DisclosureSEC source: 0000950170-24-130728 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,075,026 F1 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 16, 2024. F2 · price: The weighted average sales price of the reported transaction was $6.89 based on a range of prices between $6.83 and $6.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionCommon Stock, $0.01 Par Value | 67,536 | $1.47 | $99,277.92 |
DisclosureSEC source: 0000950170-24-130728 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,142,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantDeferred Restricted Stock Unit · Derivative | 17,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · derivative · entry 7 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,575 Underlying: Common Stock, $0.01 Par Value · 17,575 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F5 · kind: Restricted stock unit vested on November 18, 2024, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F5 · derivative.exercise_date: Restricted stock unit vested on November 18, 2024, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F5 · derivative.expiration_date: Restricted stock unit vested on November 18, 2024, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,513 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · derivative · entry 6 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,512 Underlying: Common Stock, $0.01 Par Value · 22,513 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,513 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · derivative · entry 5 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,512 Underlying: Common Stock, $0.01 Par Value · 22,513 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,513 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · derivative · entry 4 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,512 Underlying: Common Stock, $0.01 Par Value · 22,513 shares Expires 2027-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 67,539 | $6.76 | $456,563.64 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,075,026 F1 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 16, 2024. F2 · price: The weighted average sales price of the reported transaction was $6.76 based on a range of prices between $6.63 and $7.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | Exercise / conversionCommon Stock, $0.01 Par Value | 67,539 | $1.47 | $99,282.33 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,142,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 5,055 | $5.94 | $30,026.70 |
DisclosureSEC source: 0000950170-24-102041 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,075,026 F2 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 18, 2023. Read SEC document |
| August 27, 2024 Filed Aug 30, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 20,779 | $5.38 | $111,791.02 |
DisclosureSEC source: 0000950170-24-102041 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,080,081 F1 · kind: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of previously reported restricted stock units. Read SEC document |
| July 16, 2024 Filed Jul 17, 2024 23:49 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 2,836 | $5.93 | $16,817.48 |
DisclosureSEC source: 0000950170-24-084405 · ownership.xml · nonDerivative · entry 3 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,100,860 F3 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 18, 2023. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 23:49 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 11,657 | $5.83 | $67,960.31 |
DisclosureSEC source: 0000950170-24-084405 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,103,696 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 17, 2024 23:49 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 800 | $3.09 | $2,472.00 |
DisclosureSEC source: 0000950170-24-084405 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,115,353 F1 · kind: Shares acquired through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 21, 2024 Filed May 22, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $0.01 Par Value | 25,952 | $4.66 | $120,936.32 |
DisclosureSEC source: 0000950170-24-063264 · ownership.xml · nonDerivative · entry 4 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,114,553 F3 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 18, 2023. Read SEC document |
| May 18, 2024 Filed May 22, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 6,162 | $4.59 | $28,283.58 |
DisclosureSEC source: 0000950170-24-063264 · ownership.xml · nonDerivative · entry 3 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,140,505 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $0.01 Par Value | 63,720 | $4.59 | $292,474.80 |
DisclosureSEC source: 0000950170-24-063264 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,146,667 F2 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 77,420 | $4.59 | $355,357.80 |
DisclosureSEC source: 0000950170-24-063264 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,210,387 F1 · kind: A previously reported restricted stock unit award granted on May 18, 2021 vested on May 17, 2024 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on May 17, 2024 was not less than the closing price on May 17, 2021 and (ii) MannKind's total shareholder return (TSR) over the period from May 18, 2021 to May 17, 2024 was at the 74.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 198% of target, resulting in a total share delivery of 156,420 shares. The acquisition of 79,000 shares pursuant to the restricted stock award was reported in Table I of the Form 4 filed by the Reporting Person on May 18, 2021. Read SEC document |
| May 15, 2024 Filed May 18, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $.01 Par Value | 287,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-062068 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,132,967 F1 · kind: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Acquired pursuant to a Restricted Stock Unit Award: 25% vests on July 15, 2025 and each yearly anniversary thereof until fully vested. Read SEC document |
| May 13, 2024 Filed May 15, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $.01 Par Value | 3,618 | $4.31 | $15,593.58 |
DisclosureSEC source: 0000950170-24-059963 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 845,967 F2 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 18,2023. Read SEC document |
| May 10, 2024 Filed May 15, 2024 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 8,028 | $4.32 | $34,680.96 |
DisclosureSEC source: 0000950170-24-059963 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · EVP Special Projects 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,585 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2023 Filed Aug 29, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 20,328 | $4.72 | $95,948.16 |
DisclosureSEC source: 0001209191-23-047552 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,134 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 07, 2023 Filed Nov 20, 2024 02:30 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (Right to Buy) · Derivative | 45,025 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-24-128986 · ownership.xml · derivative · entry 3 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,025 Underlying: Common Stock, $0.01 Par Value · 45,025 shares Expires 2027-08-24 F3 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 7, 2023, one of the defined performance milestones was met, resulting in the vesting of the option. Read SEC document |
| May 25, 2023 Filed May 27, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantPerformance Restricted Stock Unit · Derivative | 113,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032723 · doc4.xml · derivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock, $.01 Par Value · 113,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: The performance-based restricted stock unit will vest on July 15, 2026, provided that the closing price of MannKind common stock on the Nasdaq Global Market on June 30, 2026 is not less than the closing sale price on July 1, 2023. The number of shares delivered on the vesting date, as a percentage of the target specified in Table II Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2023 until June 30, 2026 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. F3 · derivative.expiration_date: The performance-based restricted stock unit will vest on July 15, 2026, provided that the closing price of MannKind common stock on the Nasdaq Global Market on June 30, 2026 is not less than the closing sale price on July 1, 2023. The number of shares delivered on the vesting date, as a percentage of the target specified in Table II Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2023 until June 30, 2026 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. F3 · derivative.underlying_shares: The performance-based restricted stock unit will vest on July 15, 2026, provided that the closing price of MannKind common stock on the Nasdaq Global Market on June 30, 2026 is not less than the closing sale price on July 1, 2023. The number of shares delivered on the vesting date, as a percentage of the target specified in Table II Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2023 until June 30, 2026 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 25, 2023 Filed May 27, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $.01 Par Value | 92,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032723 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,324 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vests on July 15, 2024 and each yearly anniversary thereof until fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.